TIDMNSCI

RNS Number : 9575F

NetScientific PLC

26 February 2015

NetScientific plc

("NetScientific" or the "Group")

Appointment to the Board

NetScientific appoints Jonathan Paisner as Non-Executive Director

26 February 2015: NetScientific (AIM: NSCI), the biomedical and healthcare technology group is pleased to announce that Jonathan Paisner will join the Board with immediate effect as a non-executive director.

Jonathan is the founder of LMN Capital Limited, a corporate finance advisor which helps management teams access capital from a wide range of investors. He is also a consultant lawyer at law firm Mathias Gentle Page Hassan and has acted as a consultant to NetScientific. Previously, he was on the board of boutique investment bank Shore Capital. He is being appointed by the Azima Family Trusts pursuant to their rights under NetScientific's Articles of Association to nominate a director.

Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said, "Jonathan's appointment will further strengthen the Board and the Company's position in 2015. His expertise and experience, particularly in accessing capital and structuring deals, will be valuable in advancing the Group's strategy in 2015 and beyond."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Jonathan Paisner, aged 45 years, has been a director of the following companies during the five years preceding the date of this announcement:

 
 Current directorships  Past Directorships 
LMN Capital Limited     Shore Capital Group plc (now Shore Capital 
                         Group Ltd) 
LMN Capital Partners    Puma Hotels plc 
 Limited 
Beautyv Limited         Chic Lifestyle Limited 
The Fabedit Limited     Chic Retreats Limited 
                         British Friends of Hebrew University of Jerusalem 
                         Ourpinboard Limited 
                         Crowdsyndicator Limited

-Ends-

Notes to Editors

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.NetScientific.net

Contact Details

 
 Liberum (NOMAD and Broker)            Tel: +44 (0) 20 3100 2000 
  Chris Bowman / Christopher Britton 
 Instinctif Partners                   Tel: +44 (0) 20 7457 2020 
  Melanie Toyne-Sewell / Tim Watson     Email: netscientific@instinctif.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFIIFSIRFIE

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024 Click aqui para mais gráficos Netscientific.
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024 Click aqui para mais gráficos Netscientific.